Immunovia

In News

Equity research Immunovia: PancreaSure launch in the US is underway - Carlsquare Corporate Finance

Carlsquare Corporate Finance - Sep 26, 2025

Immunovia Proposes 1:100 Reverse Share Split Ahead of 2026 Meeting - TipRanks

TipRanks - Dec 17, 2025

Earnings call transcript: Immunovia Q3 2025 shows strategic shift and stock surge - Investing.com

Investing.com - Nov 26, 2025

Onconetix announces its subsidiary, Proteomedix, licenses - GlobeNewswire

GlobeNewswire - Sep 22, 2025

Equity research Immunovia, Q3 2025: US reimbursement in focus - Carlsquare Corporate Finance

Carlsquare Corporate Finance - Nov 27, 2025

Immunovia’s next-gen pancreatic cancer test shows strong performance in validation study - Medical Economics

Medical Economics - Mar 19, 2025

Immunovia’s PancreaSure Validation Study Published, Bolstering Early Pancreatic Cancer Test - TipRanks

TipRanks - Dec 22, 2025

Immunovia Q2 2025 slides: PancreaSure launch plan unveiled amid stock decline - Investing.com

Investing.com - Aug 28, 2025

Equity research Immunovia: First impression, Q3 2025 - Successful rights issue to fuel launch and reimbursement progress - Carlsquare Corporate Finance

Carlsquare Corporate Finance - Nov 26, 2025

Immunovia AB Announces EGM for Reverse Share Split and Articles Amendment - TipRanks

TipRanks - Dec 17, 2025

Onconetix subsidiary licenses biomarker technology to Immunovia - Investing.com

Investing.com - Sep 22, 2025

Equity research Immunovia: PancreaSure test achieves CPT code assignment - Carlsquare Corporate Finance

Carlsquare Corporate Finance - Jul 02, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment